All
Sabinsa strengthens position in Canada with three new patents and an NPN from Health Canada
October 28th 2020Sabinsa has been granted three new patents as well as an additional Natural Products Number (NPN) issued by Health Canada, bringing Sabinsa’s total number of products with health claims in Canada to 37.
Lonza investment to expand capsule manufacturing by 15%
October 26th 2020Lonza announced a CHF85 million (93 million USD) investment in its Capsules and Health Ingredients (CHI) Division, a dosage-form delivery partner, which will allow the company to expand its overall production capacity of capsules.
NARB recommends Benefiber discontinue ‘100% natural’ and ‘cravings’ claims
October 26th 2020A panel of the National Advertising Review Board recommended GlaxoSmithKline Consumer Healthcare, LLC discontinue “100% natural” and “clinically proven to curb cravings” claims for Benefiber Original and Benefiber Healthy Shape (Benefiber).
Probiotic usage increased following pandemic, says recent consumer survey
October 23rd 2020DuPont Nutrition and Biosciences, in collaboration with the Natural Marketing Institute recently surveyed U.S., Italian, and Chinese consumers to determine how attitudes have changed about probiotics since the COVID-19 outbreak.
Terry Naturally launches immune, stress support product called Andrographis and Ashwagandha
October 22nd 2020EuroPharma, maker of Terry Naturally, launched a new product called Andrographis and Ashwagandha featuring clinically-studied extracts for immune defense, stress support, energy and endurance, stamina, recovery, and focus.
Beneo, FMCG Gurus’ research finds consumers want immune support, eco-friendly products amid COVID-19
October 22nd 2020Results from the global survey show consumers are increasingly aware of their well-being, with a focus on immunity, and the potential connection between increased levels of environmental damage and the rise of COVID-19.
Gnosis by Lesaffre harnesses biotransformation to target wide range of product categories
October 22nd 2020Gnosis by Lesaffre has unveiled a new business strategy which is the continued focus on microorganisms and biotransformation processes such as fermentation to cultivate nutritional actives, probiotics, and yeasts that will target five key market segments.